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Chapter 8
Recombinant DNA techniques together with the mapping of the human genome have made it
feasible to treat genetic disorders at their cause instead of treating the symptoms. Viruses are,
exploiting their natural ability to cnter cells and deliver their genes into the nucleus, used to
deliver genetic material into mammalian cells to correct for the genetic disorders. However, the
human body is likely to elicit an immune response against these viruses, which will limit the
efficacy of the treatment and, moreover, may seriously endanger the patient's health.
Therefore, non-viral gene carrier systems are under development hat ultimately should be as
efficient as viral vectors in delivering their genetic cargo into cells, while being less toxic.
Cationic lipids have proofed to be safe delivery systems, although their efficiency of delivery is
still lower compared to viral vectors. To be able to enhance the transfection efficiency of
cationic lipid-DNA complexes (lipoplexes), a thorough understanding of the mecharrism of
transfection is essential. The transfection process can be divided into three steps, each ofwhich
poses a barrier to the efficiency of genc transduction, i.e., (i) binding of lipoplexes to cells,
followed by their internalization, (ii) release of DNA from the lipoplex and into the cytoplasm
and (iii) nuclear translocation of the DNA, followed by transcription. The ultirnate challenge
will be to design lipoplexes that meet such rcquirements, that cach step proceeds with the
highest efficiency possible.
To begin with, to achieve cellular binding of lipoplexes a positive charge ratio of the cationic
lipid to the DNA may be optimal. This will result in binding of the lipoplexes to the negatively
charged cell membrane by electrostatic interaction. Alternatively, ligands can be incorporated
onto the lipoplex surfacc that may specifically interact with cellular receptors. Subsequently,
the lipoplexes have to be internalized. Intcrnalization of lipoplexes by mammalian cells most
likely occurs through an endocytic process. Clathrin-mediated endocytosis was shown to
represent the main entry pathway for lipoplexes. Clathrin coated vesiclcs (CCVs) that mediate
receptor uptake can reach sizes up to 200 nm. This implies that lipoplcxes, in ordcr to be
internalized via CCVs, should not exceed a size of 200 nm. The positive charge ratio of
cationic lipid to DNA rcsults in thc formation of relatively small, condcnsed particles
comparcd to particlcs that are neutral. Thus, next to mcdiatiug ccll binding, the positive charge
ratio of the lipoplex may be important in controlling thc size of the lipoplexes. However, it has
been rcported that opsonizcd bacteria (Escherichia coli) can be internalizcd via thc pathway of
clathrin-mcdiated endocytosis, suggesting that clathrin-mediatcd cndocytosis of particles
exceeding diameters of200 nm is not unprcccdcntcd.
Summary and Perspectives
The cellular uptake of lipoplexes via an endocytic process implies that the lipoplex and/or the
DNA have to escape from the endosomal compartment prior to reaching the lysosomal
compartment, where degradation may occur. It was shown that lipoplex size and/or surface
properties influence the trafficking of lipoplexes towards lysosomes. Small lipoplexes (200-
250 nm) bearing DNA protrusions being transported more rapidly into lysosomes than bigger
(200-400 nm - I pm) and smooth lipoplexes, which could diminish their transfection
efficiency. In addition, the relatively big lipoplexes expose a greater surface for interaction
with the endosomal membrane than small lipoplexes. This would enhance the chances of
escape from the endosomal compartment, assuming that lipid mixing between the lipoplex and
the endosomal membrane is instrumental in the endosomal release of the lipoplex. Moreover,
DNA protrusions may hamper the intimate contact between the lipoplex and the endosomal
membrane, which is required for lipid mixing between these two structures. Altematively, it
could be envisaged that lipoplexes that cause endosomal membrane perturbations affect (anest)
the endosomal trafficking. Thus the absence of (large) lipoplexes in lysosomes presumably
reflects the consequence ofan efficient endosomal escape.
The ability of the lipoplex to adopt a hexagonal conformation has been correlated with efficient
transfection. Such a hexagonal phase may induce perturbations in the endosomal membrane,
which will allow the release of DNA into the cytoplasm. The presence of the helper lipid
dioleoylphosphatidylethanolamine (DOPE), which forms an inverted hexagonal phase in
isolation, in the lipoplex facilitates transfection. Next to playing a role in the hexagonal
organization of the lipoplex, DOPE facilitates the release of DNA from the lipoplex by
weakening the interaction between the cationic lipid and the DNA. More accurately, the PE-
headgroup of DOPE is responsible for the efficient release of DNA from lipoplexes. Recently,
it was shown that cationic lipids can adopt a hexagonal phase when mixed with anionic lipids,
while both populations of lipids form lamellar phases in isolation. Thus the hexagonal phase of
the lipoplex may well be promoted by the presence of acidic lipids from the endosomal
membrane. The flip-flop of phosphatidylserine (PS) from the endosomal membrane into the
lipoplex, as suggested by Xu and Szoka, thus may serve a dual purpose. First, PS neutralizes
the electrostatic interaction between the cationic lipid and the DNA, which results in lipoplex
disassembly. Second, the combination of PS with cationic lipids may promote the formation of
a hexagonal structure, which allows the transfer of DNA over the endosomal membrane into
the cytoplasm of the cell. The dual function of PS implies that the release of DNA from the
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lipoplex and into the cytoplasm occur concomitantly. It should be noted that the DNA has to be
present in a condensed state to efficiently translocate over the endosomal membrane.
The mechanism by which lipoplexes, organized in a hexagonal phase, perturb the endosomal
membrane remains unclear. Does fusion take place or is the hexagonal phase relevant to
translocation of cationic lipids into the target membrane, thereby causing a destabilization? The
relevance of lamellar to hexagonal phase transitions for the mechanism of lipoplex-mediated
transfection sets requirements to the shape, and hence the structure of the cationic lipid,
implying that the synthesis of novel compounds may take such features into account.
Cunently, hexagonai phase formation is determined by small angle X-ray- and rrP NMR-
measurements, which are techniques that are often not routinely available. A simple screening
assay for the presence of hexagonal phases, c.g. based on fluorimetry, would be of great help to
those who try to design transfection-active cationic lipids.
Following its endosomal escape the DNA has to be transported into the nucleus for expression
to occur. Similarly, antisense oligonucleotides have to reach the nucleus in order to
downregulate gene expression. Alternatively, antisense constructs may exert their function in
the cytoplasm of the cells. The half-time of DNA present in the cytoplasm is approximately 90
minutes. In order to reach the nucleus intact it should travel relatively fast through the
cytoplasm of the cell into the nucleus. Whereas oligonucleotides can freely diffuse into the
nucleus, the nuclear transfer of DNA most likely requircs active transport hrough the nuclear
pore complex (NPC).As macromolecules with a diameter of up to 36 nm were shown to pass
the NPC, the average width of a supercoiled DNA molecule of 20-80 nm would allow NPC-
mediated nuclear transfer of (exogenous) DNA. However, efficient transfection of
synchronized cell cultures has been shown to coincide with the onset of mitosis. During mitosis
the nuclear envelope disassembles. The absence of the nuclear membrane during mitosis would
greatly facilitate the uptake of DNA into the nucleus, and most likely is responsible for the
majority of DNA transfer into the nucleus during transfection. While the condensed
conformation of DNA is important for its translocation over cellular membranes, condensed
(supercoiled) DNA is also known to be transcriptionally more active than decondensed (linear)
DNA.
In summary, in order to achicve efficient transfection the lipoplcx should harbor the following
properties. First, the DNA in the lipoplexes should be in a condensed state, in order to allow
efficient translocation over the endosomal (and nuclear) membrane. A positive charge ratio of
cationic lipid to DNA may aid to form such condensed particles and in addition mediate
Summary and Perspectives
binding of the lipoplexes to the negatively charged cell surface. To allow release of the
lipoplexes from the endosomes intimate contact between these two structures should be
promoted. Herein a hexagonal conformation of the lipoplex could be helpful. Subsequently, the
transfer of acidic lipids into the lipoplex may promote the formation of a hexagonal phase
which may result in membrane perturbations, that allow DNA translocation into the cell's
cytoplasm. Little is known about the subsequent ransfer of exogenous DNA into the nucleus.
Piggybacking on proteins, e.g. histones, containing a nuclear localization signal (NLS) should
be considered as a possibility. Alternatively, during the absence of the nuclear membrane at the
time of mitosis DNA may be taken up into the nucleus.
Next to optimizing non-viral vectors for gene delivery, attention should be paid to the
development of the gene constructs. If sustained expression of the transgene is required,
integration of the gene into the host genome is necessary. However, aspecific integration of a
gene into the host genome could lead to the disturbance of normal gene functioning.
Transfection with artificial chromosomes as well as episomally stable plasmids are promising
alternatives.
While in general adherent cells can be efficiently transfected with cationic lipids, cells that
grow in suspension seem to be more resistant to lipoplex-mediated transfection. With the
current knowledge of the requirements that have to be met for cellular uptake and endosomal
release of lipoplexes, an attempt can be made to elucidate the resistance to transfection of
suspension cells. (Ex vlvo) transfection of suspension cells would be of great interest for the
treatment of, for example, blood-bome diseases such as leukemia. Moreover, transfection of
stem cells would provide a tremendous (gene)therapeutic potential for the treatment of several
disorders, such as Parkinson's disease, graft rejection, and cancer.
